- Previous Close
81.50 - Open
83.00 - Bid --
- Ask --
- Day's Range
81.60 - 83.10 - 52 Week Range
50.77 - 162.01 - Volume
176,657 - Avg. Volume
469,643 - Market Cap (intraday)
4.055B - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
78.10 - EPS (TTM)
1.05 - Earnings Date --
- Forward Dividend & Yield 0.71 (0.82%)
- Ex-Dividend Date Sep 19, 2024
- 1y Target Est
--
BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products. In addition, the company offers Exosome, a novel cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.
www.bionetcorp.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1784.TWO
View MorePerformance Overview: 1784.TWO
Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1784.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1784.TWO
View MoreValuation Measures
Market Cap
4.30B
Enterprise Value
3.05B
Trailing P/E
77.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.64
Price/Book (mrq)
3.21
Enterprise Value/Revenue
2.59
Enterprise Value/EBITDA
23.85
Financial Highlights
Profitability and Income Statement
Profit Margin
5.40%
Return on Assets (ttm)
1.50%
Return on Equity (ttm)
3.86%
Revenue (ttm)
1.16B
Net Income Avi to Common (ttm)
62.74M
Diluted EPS (ttm)
1.05
Balance Sheet and Cash Flow
Total Cash (mrq)
1.26B
Total Debt/Equity (mrq)
4.87%
Levered Free Cash Flow (ttm)
-69.83M